Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 242 entries
View as:

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Phase: N/A Priority: Normal
NCT ID: NCT04446091 Org: User:
Start: 07/01/20 End: 07/01/22 Due: 07/01/23

Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02945878 Org: User:
Start: 10/31/16 End: 05/31/18 Due: 05/31/19

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06272214 Org: User:
Start: 03/01/24 End: 03/01/29 Due: 03/01/30

Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT06350162 Org: User:
Start: 10/18/23 End: 12/31/25 Due: 12/31/26

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06308939 Org: User:
Start: 03/08/24 End: 08/31/26 Due: 08/31/27

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

Phase: N/A Priority: Normal
NCT ID: NCT04319601 Org: User:
Start: 03/13/20 End: 12/31/22 Due: 12/31/23

A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03280134 Org: User:
Start: 10/15/18 End: 06/30/20 Due: 06/30/21

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03940001 Org: User:
Start: 05/01/19 End: 05/01/22 Due: 05/01/23

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT05461690 Org: User:
Start: 09/01/22 End: 06/30/25 Due: 06/30/26

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02813967 Org: User:
Start: 06/30/16 End: 08/31/20 Due: 08/31/21

Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03638648 Org: User:
Start: 11/01/19 End: 12/30/22 Due: 12/30/23

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06031597 Org: User:
Start: 09/15/23 End: 12/31/25 Due: 12/31/26

Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05813626 Org: User:
Start: 04/03/23 End: 10/30/27 Due: 10/30/28

CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled Study

Phase: N/A Priority: Normal
NCT ID: NCT06609551 Org: User:
Start: 07/03/24 End: 12/31/34 Due: 12/31/35

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Phase: N/A Priority: Normal
NCT ID: NCT05514275 Org: User:
Start: 08/01/22 End: 08/01/28 Due: 08/01/29

S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01175447 Org: User:
Start: 02/28/10 End: 12/31/11 Due: 12/31/12

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase: N/A Priority: Normal
NCT ID: NCT04291092 Org: User:
Start: 01/01/20 End: 06/30/23 Due: 06/30/24

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05103293 Org: User:
Start: 11/01/21 End: 12/10/23 Due: 12/10/24

Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06832228 Org: User:
Start: 09/01/24 End: 09/01/26 Due: 09/01/27

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05387044 Org: User:
Start: 05/01/22 End: 04/30/24 Due: 04/30/25

Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT05007587 Org: User:
Start: 07/01/21 End: 06/30/23 Due: 06/30/24

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06134011 Org: User:
Start: 09/10/23 End: 09/10/24 Due: 09/10/25

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06741020 Org: User:
Start: 03/01/25 End: 12/30/26 Due: 12/30/27

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Phase: N/A Priority: Normal
NCT ID: NCT06178926 Org: User:
Start: 08/01/23 End: 12/30/24 Due: 12/30/25

Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05669807 Org: User:
Start: 12/31/22 End: 11/30/25 Due: 11/30/26